Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
14
self-reported band not used
Founded
2020
6 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Description
Solution Biologics Sdn. Bhd. ("SOLBIO") has entered into a market authorisation , manufacturing and commercialisation agreement with CanSino Biologics Inc.based in Tianjin, China ("CanSinoBIO", SHSE:688185, HKEX:06185) for the supply of vaccines especially the Covid-19 vaccine into Malaysia. As part of the manufacturing agreement , SOLBIO is in the process of establishing a Fill & Finish Facility in our current building at Technology Park Malaysia. We are also responsible to market the vaccine, co-developed by CanSinoBIO and the Beijing Institute of Biotechnology, Academy of Military Medical Sciences (BIB). to the ASEAN countries namely Philippines , Thailand, Singapore, Myanmar , Vietnam , Cambodia , Laos and Brunei .
Biologics and vaccines represent one of the fastest growing classes of therapeutic molecules in modern healthcare. The annual global biologics market is expected to be approximately USD 380 billion by 2024, representing a relatively higher growth rate (~8%) compared to conventional pharmaceuticals. Currently, more than 350 biologics are commercially presented in the biopharmaceuticals market.
In the area of vaccines, there's no doubt that immunization saves millions of lives every year from vaccine-preventable diseases and one of the success stories in global health. More than 20 life-threatening diseases can now be prevented by immunization, and new vaccines for major killers like meningitis, cervical cancer, cholera and influenza are now being introduced in many countries. Today, vaccination is increasingly protecting health among people of all ages.
With the incorporation of Solution Biologics Sdn. Bhd., as a biopharmaceutical company, SGB will enter into the life sciences business and will work to deliver vaccines and biologics that will help millions in Malaysia and the ASEAN region.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | MY |
All codes: MY
Addresses
- MYPT 13796, Jalan Tekno Usahawan 2; Federal Territory of Kuala Lumpur, Kuala Lumpur 57000Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
How many people work at Solution Biologics Sdn. Bhd.?
14 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does Solution Biologics Sdn. Bhd. have offices?
One address on record, Malaysia only. Primary: PT 13796, Jalan Tekno Usahawan 2, Federal Territory of Kuala Lumpur, Kuala Lumpur 57000.
Has Solution Biologics Sdn. Bhd. raised funding?
None linked to this brand.
Which companies are listed alongside Solution Biologics Sdn. Bhd.?
7 profiles list Solution Biologics Sdn. Bhd. as a peer — 79th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Vital Healthcare Sdn Bhd and Solution Engineering Sdn Bhd list it back.